Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Recruiting 5Active not recruiting 3Withdrawn 1Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 1Genitourinary 1

Conditions

Prostatic Neoplasms 42Lung Neoplasms 39Leukemia, Myeloid, Acute 36Carcinoma, Non-Small-Cell Lung 33Neoplasm Metastasis 29Breast Neoplasms 28Myelodysplastic Syndromes 20Lymphoma, Large B-Cell, Diffuse 20Leukemia, Lymphocytic, Chronic, B-Cell 19Colorectal Neoplasms 19Pancreatic Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Multiple Myeloma 15Triple Negative Breast Neoplasms 14Ovarian Neoplasms 14Glioblastoma 14Carcinoma, Renal Cell 13Burkitt Lymphoma 13Squamous Cell Carcinoma of Head and Neck 12Urinary Bladder Neoplasms 10Melanoma 10Lymphoma, Mantle-Cell 10Endometrial Neoplasms 10Carcinoma, Hepatocellular 10Myeloproliferative Disorders 9Mouth Neoplasms 9Leukemia, Myelomonocytic, Chronic 9Carcinoma 9Brain Neoplasms 9Oropharyngeal Neoplasms 8

Interventions

Capecitabine 29Oxaliplatin 28Fluorouracil 16Radiotherapy 15Drug Therapy 11Leucovorin 10Bevacizumab 10Surgical Procedures, Operative 9Chemoradiotherapy 8Radiation 7sintilimab 6Consolidation Chemotherapy 6tislelizumab 5spartalizumab 5XELOX 5Specimen Handling 5Irinotecan 5Folfox protocol 5trifluridine tipiracil drug combination 4Neoadjuvant Therapy 4Endoscopy 4Cetuximab 4Biopsy 4toripalimab 3pembrolizumab 3irinotecan sucrosofate 3X-Rays 3Radiotherapy, Intensity-Modulated 3Proctectomy 3Mastectomy, Segmental 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Rectal Neoplasms × Specimen Handling × Clear all
NCT07407647 2026-04-21

Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
25 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT07405476 2026-04-17

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Emory University

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05722288 2025-08-29

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

City of Hope Medical Center

Phase 2 Recruiting
60 enrolled
GastrointestinalGenitourinary

Prostatic Neoplasms, Rectal Neoplasms

NCT06834126 2025-07-18

Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial

City of Hope Medical Center

Phase 1 Recruiting
36 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06780787 2025-06-26

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

City of Hope Medical Center

Phase 2 Recruiting
26 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡